The final session of SABCS 2021 highlighted some of the most important breast cancer results from the meeting and put the findings into context for day-to-day clinical practice.

A panel of experts discussed some of the latest advances in early and advanced breast cancer, basic science, and translational research during the special session Year in Review on Friday.

In her plenary lecture on Friday, medical oncologist Lisa A. Carey, MD, ScM, discussed triple negative breast cancer, including advancements in treatment options and implications for population health.

During the plenary lecture on Thursday, Mitchell Dowsett, PhD, FMedSci, looked at genetic profiling from early research to clinical utility and addressed clinically critical questions that have yet to be answered.